Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis

H Matsui, S Lazareno and NJ Birdsall

Medical Research Council Collaborative Centre, London, England.

In an attempt to locate the allosteric site on muscarinic receptors to which gallamine binds, 21 residues in the putative external loops and loop/transmembrane helix interfaces have been mutated to alanine. These residues are conserved in mammalian m1-m5 receptors. All mutant receptors can be expressed in COS-7 cells at high levels and appear to be functional, in that acetylcholine binding is sensitive to GTP. The gallamine binding site does not appear to involve the first, second, and most of the third extracellular loops. Tryptophan-400 and -101 inhibit gallamine binding when mutated to alanine or to phenylalanine and may form part of the allosteric site. Several mutations also affect antagonist binding. Surprisingly, tryptophan-91, a residue conserved in monoamine and peptide receptors, is important for antagonist binding. This residue, present in the middle of the first extracellular loop, may have a structural role in many G protein-coupled receptors. Antagonist binding is also affected by mutations of tryptophan-101 and tyrosine-404 to alanine or phenylalanine. In a helical wheel model, trytophan-101 and tyrosine-404, in conjunction with serine-78, aspartate-105, and tyrosine-408, form a cluster of residues that have been reported to affect antagonist binding when mutated, and they may therefore be part of the antagonist binding site. It is suggested that the allosteric site may be located close to and just extracellular to the antagonist binding site. The binding of methoctramine, an antagonist with allosteric properties, is not substantially affected by mutations at tryptophan-91, -101, and -400 and tyrosine-404, and thus these amino acids are not important for its binding. The binding of himbacine, another antagonist with allosteric properties, is affected by these mutations but in a manner different from that of gallamine or competitive antagonists. It has not been possible to determine whether methoctramine and himbacine bind exclusively to the allosteric site or to both the competitive site and the allosteric site.

Volume 47, Issue 1, pp. 88-98, 01/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				C. Fruchart-Gaillard, G. Mourier, C. Marquer, E. Stura, N. J. M. Birdsall, and D. Servent Different Interactions between MT7 Toxin and the Human Muscarinic M1 Receptor in Its Free and N-Methylscopolamine-Occupied States Mol. Pharmacol., December 1, 2008; 74(6): 1554 - 1563. [Abstract] [Full Text] [PDF]

				F. J. Ehlert and M. T. Griffin Two-State Models and the Analysis of the Allosteric Effect of Gallamine at the M2 Muscarinic Receptor J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 1039 - 1060. [Abstract] [Full Text] [PDF]

				J. A. Goodwin, E. C. Hulme, C. J. Langmead, and B. G. Tehan Roof and Floor of the Muscarinic Binding Pocket: Variations in the Binding Modes of Orthosteric Ligands Mol. Pharmacol., December 1, 2007; 72(6): 1484 - 1496. [Abstract] [Full Text] [PDF]

				D. Jager, C. Schmalenbach, S. Prilla, J. Schrobang, A. Kebig, M. Sennwitz, E. Heller, C. Trankle, U. Holzgrabe, H.-D. Holtje, et al. Allosteric Small Molecules Unveil a Role of an Extracellular E2/Transmembrane Helix 7 Junction for G Protein-coupled Receptor Activation J. Biol. Chem., November 30, 2007; 282(48): 34968 - 34976. [Abstract] [Full Text] [PDF]

				V. A. Avlani, K. J. Gregory, C. J. Morton, M. W. Parker, P. M. Sexton, and A. Christopoulos Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands J. Biol. Chem., August 31, 2007; 282(35): 25677 - 25686. [Abstract] [Full Text] [PDF]

				L. T. May, V. A. Avlani, C. J. Langmead, H. J. Herdon, M. D. Wood, P. M. Sexton, and A. Christopoulos Structure-Function Studies of Allosteric Agonism at M2 Muscarinic Acetylcholine Receptors Mol. Pharmacol., August 1, 2007; 72(2): 463 - 476. [Abstract] [Full Text] [PDF]

				S. Prilla, J. Schrobang, J. Ellis, H.-D. Holtje, and K. Mohr Allosteric Interactions with Muscarinic Acetylcholine Receptors: Complex Role of the Conserved Tryptophan M2422Trp in a Critical Cluster of Amino Acids for Baseline Affinity, Subtype Selectivity, and Cooperativity Mol. Pharmacol., July 1, 2006; 70(1): 181 - 193. [Abstract] [Full Text] [PDF]

				C. Fruchart-Gaillard, G. Mourier, C. Marquer, A. Menez, and D. Servent Identification of Various Allosteric Interaction Sites on M1 Muscarinic Receptor Using 125I-Met35-Oxidized Muscarinic Toxin 7 Mol. Pharmacol., May 1, 2006; 69(5): 1641 - 1651. [Abstract] [Full Text] [PDF]

				J. M. Klco, G. V. Nikiforovich, and T. J. Baranski Genetic Analysis of the First and Third Extracellular Loops of the C5a Receptor Reveals an Essential WXFG Motif in the First Loop J. Biol. Chem., April 28, 2006; 281(17): 12010 - 12019. [Abstract] [Full Text] [PDF]

				C. J. Langmead, V. A. H. Fry, I. T. Forbes, C. L. Branch, A. Christopoulos, M. D. Wood, and H. J. Herdon Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist Mol. Pharmacol., January 1, 2006; 69(1): 236 - 246. [Abstract] [Full Text] [PDF]

				H. Lan, C. J. DuRand, M. M. Teeter, and K. A. Neve Structural Determinants of Pharmacological Specificity Between D1 and D2 Dopamine Receptors Mol. Pharmacol., January 1, 2006; 69(1): 185 - 194. [Abstract] [Full Text] [PDF]

				J. Wess Allosteric Binding Sites on Muscarinic Acetylcholine Receptors Mol. Pharmacol., December 1, 2005; 68(6): 1506 - 1509. [Abstract] [Full Text] [PDF]

				X.-P. Huang, S. Prilla, K. Mohr, and J. Ellis Critical Amino Acid Residues of the Common Allosteric Site on the M2 Muscarinic Acetylcholine Receptor: More Similarities than Differences between the Structurally Divergent Agents Gallamine and Bis(ammonio)alkane-Type Hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide Mol. Pharmacol., September 1, 2005; 68(3): 769 - 778. [Abstract] [Full Text] [PDF]

				J. Jakubik, A. Krejci, and V. Dolezal Asparagine, Valine, and Threonine in the Third Extracellular Loop of Muscarinic Receptor Have Essential Roles in the Positive Cooperativity of Strychnine-Like Allosteric Modulators J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 688 - 696. [Abstract] [Full Text] [PDF]

				A. Lanzafame and A. Christopoulos Investigation of the Interaction of a Putative Allosteric Modulator, N-(2,3-Diphenyl-1,2,4-thiadiazole-5-(2H)-ylidene) Methanamine Hydrobromide (SCH-202676), with M1 Muscarinic Acetylcholine Receptors J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 830 - 837. [Abstract] [Full Text] [PDF]

				K. A. Selz, A. J. Mandell, M. F. Shlesinger, V. Arcuragi, and M. J. Owens Designing Human m1 Muscarinic Receptor-Targeted Hydrophobic Eigenmode Matched Peptides as Functional Modulators Biophys. J., March 1, 2004; 86(3): 1308 - 1331. [Abstract] [Full Text] [PDF]

				U. Voigtlander, K. Johren, M. Mohr, A. Raasch, C. Trankle, S. Buller, J. Ellis, H.-D. Holtje, and K. Mohr Allosteric Site on Muscarinic Acetylcholine Receptors: Identification of Two Amino Acids in the Muscarinic M2 Receptor That Account Entirely for the M2/M5 Subtype Selectivities of Some Structurally Diverse Allosteric Ligands in N-Methylscopolamine-Occupied Receptors Mol. Pharmacol., July 1, 2003; 64(1): 21 - 31. [Abstract] [Full Text] [PDF]

				Z.-G. Gao, S.-K. Kim, A. S. Gross, A. Chen, J. B. Blaustein, and K. A. Jacobson Identification of Essential Residues Involved in the Allosteric Modulation of the Human A3 Adenosine Receptor Mol. Pharmacol., May 1, 2003; 63(5): 1021 - 1031. [Abstract] [Full Text] [PDF]

				O. Madsen, D. Willemsen, B. M. Ursing, U. Arnason, and W. W. de Jong Molecular Evolution of the Mammalian Alpha 2B Adrenergic Receptor Mol. Biol. Evol., December 1, 2002; 19(12): 2150 - 2160. [Abstract] [Full Text] [PDF]

				A. Christopoulos and T. Kenakin G Protein-Coupled Receptor Allosterism and Complexing Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374. [Abstract] [Full Text] [PDF]

				T. A. Spalding, C. Trotter, N. Skjarbak, T. L. Messier, E. A. Currier, E. S. Burstein, D. Li, U. Hacksell, and M. R. Brann Discovery of an Ectopic Activation Site on the M1 Muscarinic Receptor Mol. Pharmacol., June 1, 2002; 61(6): 1297 - 1302. [Abstract] [Full Text] [PDF]

				S. Buller, D. P. Zlotos, K. Mohr, and J. Ellis Allosteric Site on Muscarinic Acetylcholine Receptors: A Single Amino Acid in Transmembrane Region 7 Is Critical to the Subtype Selectivities of Caracurine V Derivatives and Alkane-Bisammonium Ligands Mol. Pharmacol., January 1, 2002; 61(1): 160 - 168. [Abstract] [Full Text] [PDF]

				J. L. Krajewski, I. M. Dickerson, and L. T. Potter Site-Directed Mutagenesis of m1-Toxin1: Two Amino Acids Responsible for Stable Toxin Binding to M1 Muscarinic Receptors Mol. Pharmacol., October 1, 2001; 60(4): 725 - 731. [Abstract] [Full Text] [PDF]

				A. Krejci and S. Tucek Changes of Cooperativity between N-Methylscopolamine and Allosteric Modulators Alcuronium and Gallamine Induced by Mutations of External Loops of Muscarinic M3 Receptors Mol. Pharmacol., October 1, 2001; 60(4): 761 - 767. [Abstract] [Full Text] [PDF]

				J. A. Ballesteros, L. Shi, and J. A. Javitch Structural Mimicry in G Protein-Coupled Receptors: Implications of the High-Resolution Structure of Rhodopsin for Structure-Function Analysis of Rhodopsin-Like Receptors Mol. Pharmacol., July 1, 2001; 60(1): 1 - 19. [Abstract] [Full Text]

				J. Ellis and M. Seidenberg Interactions of Alcuronium, TMB-8, and Other Allosteric Ligands with Muscarinic Acetylcholine Receptors: Studies with Chimeric Receptors Mol. Pharmacol., April 13, 2001; 58(6): 1451 - 1460. [Abstract] [Full Text]

				A. L. Gnagey, M. Seidenberg, and J. Ellis Site-Directed Mutagenesis Reveals Two Epitopes Involved in the Subtype Selectivity of the Allosteric Interactions of Gallamine at Muscarinic Acetylcholine Receptors Mol. Pharmacol., December 1, 1999; 56(6): 1245 - 1253. [Abstract] [Full Text]

				X.-P. Huang, F. E. Williams, S. M. Peseckis, and W. S. Messer Jr. Differential Modulation of Agonist Potency and Receptor Coupling by Mutations of Ser388Tyr and Thr389Pro at the Junction of Transmembrane Domain VI and the Third Extracellular Loop of Human M1 Muscarinic Acetylcholine Receptors Mol. Pharmacol., October 1, 1999; 56(4): 775 - 783. [Abstract] [Full Text]

				Z.-L. Lu and E. C. Hulme The Functional Topography of Transmembrane Domain 3 of the M1 Muscarinic Acetylcholine Receptor, Revealed by Scanning Mutagenesis J. Biol. Chem., March 12, 1999; 274(11): 7309 - 7315. [Abstract] [Full Text] [PDF]

				J. Jakubik and J. Wess Use of a Sandwich Enzyme-linked Immunosorbent Assay Strategy to Study Mechanisms of G Protein-coupled Receptor Assembly J. Biol. Chem., January 15, 1999; 274(3): 1349 - 1358. [Abstract] [Full Text] [PDF]

				E. S. Burstein, T. A. Spalding, and M. R. Brann The Second Intracellular Loop of the m5 Muscarinic Receptor Is the Switch Which Enables G-protein Coupling J. Biol. Chem., September 18, 1998; 273(38): 24322 - 24327. [Abstract] [Full Text] [PDF]

				T. A. Spalding, E. S. Burstein, S. C. Henderson, K. R. Ducote, and M. R. Brann Identification of a Ligand-dependent Switch within a Muscarinic Receptor J. Biol. Chem., August 21, 1998; 273(34): 21563 - 21568. [Abstract] [Full Text] [PDF]

				M. P. Caulfield and N. J. M. Birdsall International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors Pharmacol. Rev., June 1, 1998; 50(2): 279 - 290. [Abstract] [Full Text] [PDF]

				R. A. Leppik, S. Lazareno, A. Mynett, and N. J. M. Birdsall Characterization of the Allosteric Interactions between Antagonists and Amiloride Analogues at the Human alpha 2A-Adrenergic Receptor Mol. Pharmacol., May 1, 1998; 53(5): 916 - 925. [Abstract] [Full Text]

				S. Lazareno, P. Gharagozloo, D. Kuonen, A. Popham, and N. J. M. Birdsall Subtype-Selective Positive Cooperative Interactions between Brucine Analogues and Acetylcholine at Muscarinic Receptors: Radioligand Binding Studies Mol. Pharmacol., March 1, 1998; 53(3): 573 - 589. [Abstract] [Full Text]

				J. Liu, T. Schöneberg, M. van Rhee, and Jür. Wess Mutational Analysis of the Relative Orientation of Transmembrane Helices I and VII in G Protein-coupled Receptors J. Biol. Chem., August 18, 1995; 270(33): 19532 - 19539. [Abstract] [Full Text] [PDF]

				Z.-L. Lu, J. W. Saldanha, and E. C. Hulme Transmembrane Domains 4 and 7 of the M1 Muscarinic Acetylcholine Receptor Are Critical for Ligand Binding and the Receptor Activation Switch J. Biol. Chem., August 31, 2001; 276(36): 34098 - 34104. [Abstract] [Full Text] [PDF]